SG11201404144PA - 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives - Google Patents
4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivativesInfo
- Publication number
- SG11201404144PA SG11201404144PA SG11201404144PA SG11201404144PA SG11201404144PA SG 11201404144P A SG11201404144P A SG 11201404144PA SG 11201404144P A SG11201404144P A SG 11201404144PA SG 11201404144P A SG11201404144P A SG 11201404144PA SG 11201404144P A SG11201404144P A SG 11201404144PA
- Authority
- SG
- Singapore
- Prior art keywords
- benzoimidazol
- thiazole compounds
- aza derivatives
- related aza
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IBPCT/IB2012/050489 | 2012-02-02 | ||
PCT/IB2013/050870 WO2013114332A1 (en) | 2012-02-02 | 2013-02-01 | 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201404144PA true SG11201404144PA (en) | 2014-10-30 |
Family
ID=48014121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201404144PA SG11201404144PA (en) | 2012-02-02 | 2013-02-01 | 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives |
Country Status (21)
Country | Link |
---|---|
US (1) | US9266876B2 (ru) |
EP (1) | EP2809668B1 (ru) |
JP (1) | JP6073931B2 (ru) |
KR (1) | KR101800607B1 (ru) |
CN (1) | CN104093715B (ru) |
AU (1) | AU2013216354B2 (ru) |
BR (1) | BR112014018714A8 (ru) |
CA (1) | CA2861020C (ru) |
CL (1) | CL2014002048A1 (ru) |
EA (1) | EA027595B1 (ru) |
ES (1) | ES2632237T3 (ru) |
HK (1) | HK1203939A1 (ru) |
IL (1) | IL233872A (ru) |
MX (1) | MX352181B (ru) |
MY (1) | MY170524A (ru) |
NZ (1) | NZ629795A (ru) |
PH (1) | PH12014501540A1 (ru) |
PL (1) | PL2809668T3 (ru) |
SG (1) | SG11201404144PA (ru) |
UA (1) | UA113638C2 (ru) |
WO (1) | WO2013114332A1 (ru) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX363432B (es) * | 2013-07-22 | 2019-03-22 | Idorsia Pharmaceuticals Ltd | Derivados 1-(piperazin-1-il)-2-([1,2,4]triazol-1-il)-etanona. |
US10087151B2 (en) | 2014-01-09 | 2018-10-02 | The J. David Gladstone Institutes, A Testimentary Trust Established Under The Will Of J. David Gladstone | Substituted benzoxazine and related compounds |
AR099789A1 (es) | 2014-03-24 | 2016-08-17 | Actelion Pharmaceuticals Ltd | Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina |
AR103399A1 (es) | 2015-01-15 | 2017-05-10 | Actelion Pharmaceuticals Ltd | Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3 |
DK3245203T3 (en) | 2015-01-15 | 2019-02-18 | Idorsia Pharmaceuticals Ltd | HYDROXYALKYL-PIPERAZINE DERIVATIVES AS CXCR3 RECEPTOR MODULATORS |
GB201506658D0 (en) | 2015-04-20 | 2015-06-03 | Cellcentric Ltd | Pharmaceutical compounds |
GB201506660D0 (en) | 2015-04-20 | 2015-06-03 | Cellcentric Ltd | Pharmaceutical compounds |
WO2018011265A1 (en) | 2016-07-13 | 2018-01-18 | Idorsia Pharmaceuticals Ltd | Hydroxyalkyl-piperazine derivatives as cxcr3 receptor modulators |
FR3067028B1 (fr) | 2017-06-06 | 2019-07-12 | Adpuerivitam | Modulateurs de recepteurs nmda, compositions les comprenant et utilisation de ces composes dans le traitement de maladies impliquant le systeme nerveux central |
CN116635029A (zh) * | 2020-10-16 | 2023-08-22 | 圣路易斯大学 | Rev-erb激动剂 |
Family Cites Families (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004523530A (ja) | 2001-01-23 | 2004-08-05 | イーライ・リリー・アンド・カンパニー | メラノコルチン受容体アゴニストとしてのピペラジンおよびピペリジン誘導体 |
CA2438272A1 (en) | 2001-03-02 | 2002-10-10 | John Macor | Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
GB0229618D0 (en) * | 2002-12-19 | 2003-01-22 | Cancer Rec Tech Ltd | Pyrazole compounds |
GB0315203D0 (en) | 2003-06-28 | 2003-08-06 | Celltech R&D Ltd | Chemical compounds |
WO2005035534A1 (ja) | 2003-10-08 | 2005-04-21 | Ono Pharmaceutical Co., Ltd. | 複素ビシクロ環および複素トリシクロ環化合物およびその医薬 |
US20050124625A1 (en) | 2003-10-21 | 2005-06-09 | Salvati Mark E. | Piperazine derivatives and their use as modulators of nuclear hormone receptor function |
US20050119252A1 (en) | 2003-10-22 | 2005-06-02 | Neurocrine Biosciences, Inc. | Ligands of melanocortin receptors and compositions and methods related thereto |
GB0325956D0 (en) | 2003-11-06 | 2003-12-10 | Addex Pharmaceuticals Sa | Novel compounds |
JP2007512364A (ja) | 2003-11-21 | 2007-05-17 | アレイ バイオファーマ、インコーポレイテッド | Aktプロテインキナーゼインヒビター |
MY140489A (en) | 2003-12-26 | 2009-12-31 | Eisai R&D Man Co Ltd | 1,2-di (cyclic) substituted benzene compounds |
US20060276465A1 (en) | 2003-12-26 | 2006-12-07 | Eisai R&D Management Co., Ltd. | 1,2-di(cyclic) substituted benzene compounds |
WO2006088840A1 (en) | 2005-02-16 | 2006-08-24 | Schering Corporation | Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity |
WO2006088919A2 (en) | 2005-02-16 | 2006-08-24 | Schering Corporation | Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
CN101142209A (zh) | 2005-02-16 | 2008-03-12 | 先灵公司 | 具有cxcr3拮抗剂活性的吡嗪基取代的哌嗪-哌啶 |
CA2598456A1 (en) | 2005-02-16 | 2006-08-24 | Schering Corporation | Heterocyclic substituted piperazines with cxcr3 antagonist activity |
EP1858895B1 (en) | 2005-02-16 | 2012-06-20 | Schering Corporation | Piperazine-piperidines with cxcr3 antagonist activity |
CA2598460C (en) | 2005-02-16 | 2013-05-07 | Schering Corporation | Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
MX2007009949A (es) | 2005-02-16 | 2007-09-26 | Schering Corp | Pirazinil-piperazin-piperidinas sustituidas con heteroarilo con actividad antagonista de cxcr3. |
AU2006215399B2 (en) * | 2005-02-18 | 2010-12-09 | Astrazeneca Ab | Antibacterial piperidine derivatives |
US20080312215A1 (en) | 2005-06-28 | 2008-12-18 | Pharmacopeia Drug Discovery, Inc. | Substituted [1,4]-diazepanes as CXCR3 antagonists and their use in the treatment of inflammatory disorders |
US7754724B2 (en) | 2005-06-30 | 2010-07-13 | Dow Agrosciences Llc | N-substituted piperazines |
TW200738701A (en) | 2005-07-26 | 2007-10-16 | Du Pont | Fungicidal carboxamides |
WO2007047202A1 (en) | 2005-10-11 | 2007-04-26 | Schering Corporation | Substituted heterocyclic compounds with cxcr3 antagonist activity |
EP1957076A2 (en) * | 2005-11-29 | 2008-08-20 | Merck & Co., Inc. | Thiazole derivatives as cxcr3 receptor modulators |
EP1962605A2 (en) | 2005-12-12 | 2008-09-03 | Merck & Co., Inc. | 2-arylthiazole derivatives as cxcr3 receptor modulators |
WO2007076318A2 (en) | 2005-12-21 | 2007-07-05 | Smithkline Beecham Corporation | Camphor-derived cxcr3 antagonists |
WO2007100610A2 (en) | 2006-02-23 | 2007-09-07 | Merck & Co., Inc. | Pyridine, pyrimidine and pyrazine derivatives as cxcr3 receptor modulators |
CA2646958A1 (en) | 2006-03-21 | 2007-09-27 | Schering Corporation | Heterocyclic substituted pyridine compounds with cxcr3 antagonist activity |
FR2903405B1 (fr) | 2006-07-04 | 2011-09-09 | Pasteur Institut | Composes a effet potentialisateur de l'activite de l'ethionamide et leurs applications |
JP2009543782A (ja) | 2006-07-14 | 2009-12-10 | シェーリング コーポレイション | Cxcr3アンタゴニスト活性を有している新規の複素環置換ピペラジン化合物 |
WO2008013622A2 (en) | 2006-07-27 | 2008-01-31 | E. I. Du Pont De Nemours And Company | Fungicidal azocyclic amides |
CN101558066A (zh) * | 2006-08-17 | 2009-10-14 | 阿斯利康(瑞典)有限公司 | 具有抗菌活性的吡咯衍生物 |
US20120157466A1 (en) | 2006-12-22 | 2012-06-21 | Qingbei Zeng | Heterocyclic compounds with cxcr3 antagonist activity |
CA2669412A1 (en) | 2007-01-23 | 2008-07-31 | Xencor, Inc. | Optimized cd40 antibodies and methods of using the same |
US8420673B2 (en) | 2007-01-25 | 2013-04-16 | E I Du Pont De Nemours And Company | Fungicidal amides |
MX2010001400A (es) | 2007-08-03 | 2010-04-22 | Schering Corp | Metodo para tratar enfermedades mediadas cxcr3 usando piperazinas heterociclicas sustituidas. |
TWI428091B (zh) * | 2007-10-23 | 2014-03-01 | Du Pont | 殺真菌劑混合物 |
EP2234971A1 (en) | 2007-12-18 | 2010-10-06 | Schering Corporation | Process and intermediates for the synthesis of heterocyclic substituted piperazines with cxcr3 antagonist activity |
CN101965347B (zh) * | 2008-01-09 | 2013-01-02 | 阵列生物制药公司 | 作为激酶抑制剂的吡唑并吡啶 |
EP2402332A3 (en) | 2008-01-25 | 2014-10-29 | E.I. Du Pont De Nemours And Company | Fungicidal heterocyclic compounds |
EP2238133A2 (en) | 2008-01-25 | 2010-10-13 | E. I. du Pont de Nemours and Company | Fungicidal amides |
PE20091576A1 (es) | 2008-02-19 | 2009-11-05 | Sanofi Aventis | DERIVADOS DE 3-(AMIDO O SULFAMIDO)-4-(4-AZINIL SUSTITUIDO)BENZAMIDA COMO INHIBIDORES DEL RECEPTOR DE QUIMIOQUINAS CxCR3 |
US8569509B2 (en) | 2008-04-30 | 2013-10-29 | Bayer Intellectual Property Gmbh | Thiazole-4-carboxylic acid esters and thioesters as plant protection agents |
US8343975B2 (en) * | 2008-09-11 | 2013-01-01 | Penglie Zhang | 4-amino-3-(imidazolyl)-pyrazolo[3,4-D]pyrimidines |
WO2010037479A1 (de) | 2008-10-01 | 2010-04-08 | Bayer Cropscience Ag | Heterocyclyl substituierte thiazole als pflanzenschutzmittel |
KR101052065B1 (ko) | 2008-10-15 | 2011-07-27 | 한국과학기술연구원 | 칼슘이온 채널 조절제로서 유효한 피라졸릴메틸아민-피페라진 유도체와 이의 제조방법 |
AR074411A1 (es) | 2008-12-02 | 2011-01-12 | Du Pont | Compuestos heterociclicos fungicidas |
BRPI0923366A2 (pt) | 2008-12-11 | 2019-09-24 | Bayer Cropscience Ag | éteres e hodrazonas de oxima de tiazolila como agentes protetors de culturas. |
US8362249B2 (en) | 2009-04-27 | 2013-01-29 | Boehringer Ingelheim International Gmbh | CXCR3 receptor antagonists |
JP5807971B2 (ja) * | 2009-04-27 | 2015-11-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cxcr3受容体アンタゴニスト |
EP2272846A1 (de) | 2009-06-23 | 2011-01-12 | Bayer CropScience AG | Thiazolylpiperidin Derivate als Fungizide |
UA107938C2 (en) | 2009-08-12 | 2015-03-10 | Syngenta Participations Ag | Heterocycles with microbicidal properties |
GEP20146079B (en) | 2009-08-12 | 2014-04-25 | Syngenta Participations Ag | Microbiocidal heterocycles |
WO2011051243A1 (en) | 2009-10-29 | 2011-05-05 | Bayer Cropscience Ag | Active compound combinations |
BR112012010242B1 (pt) | 2009-10-30 | 2018-03-20 | Bayer Intellectual Property Gmbh | Derivados de heteroarilpiperidina e heteroarilpiperazina |
PT2516426E (pt) | 2009-12-21 | 2015-12-01 | Bayer Cropscience Ag | Bis(difluorometil)pirazóis como fungicidas |
WO2011084985A1 (en) | 2010-01-07 | 2011-07-14 | Boehringer Ingelheim International Gmbh | Cxcr3 receptor antagonists |
MX2012012460A (es) | 2010-04-28 | 2012-11-21 | Bayer Cropscience Ag | Derivados de cetoheteroarilpiperidina y de cetoheteroarilpiperazin a como fungicidas. |
US8815775B2 (en) | 2010-05-18 | 2014-08-26 | Bayer Cropscience Ag | Bis(difluoromethyl)pyrazoles as fungicides |
KR20130109975A (ko) | 2010-05-20 | 2013-10-08 | 이 아이 듀폰 디 네모아 앤드 캄파니 | 살진균제 옥심 및 하이드라존 |
JP2013528169A (ja) | 2010-05-27 | 2013-07-08 | バイエル・クロップサイエンス・アーゲー | 殺菌剤としてのピリジニルカルボン酸誘導体 |
US20120122928A1 (en) | 2010-08-11 | 2012-05-17 | Bayer Cropscience Ag | Heteroarylpiperidine and -Piperazine Derivatives as Fungicides |
US8759527B2 (en) | 2010-08-25 | 2014-06-24 | Bayer Cropscience Ag | Heteroarylpiperidine and -piperazine derivatives as fungicides |
JP5918773B2 (ja) | 2010-10-27 | 2016-05-18 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH | 殺菌剤としてのヘテロアリールピペリジンおよびヘテロアリールピペラジン誘導体 |
WO2012069633A1 (en) | 2010-11-25 | 2012-05-31 | Syngenta Participations Ag | Microbicidal heterocycles |
MX2013006936A (es) | 2010-12-17 | 2013-07-22 | Du Pont | Ambas azociclicas fungicidas. |
MX352307B (es) | 2011-02-01 | 2017-11-17 | Bayer Ip Gmbh | Derivados de heteroarilpiperidina y -piperazina como fungicidas. |
US8748432B2 (en) | 2011-02-10 | 2014-06-10 | Syngenta Participations Ag | Microbiocidal pyrazole derivatives |
WO2012107477A1 (en) | 2011-02-10 | 2012-08-16 | Syngenta Participations Ag | Microbiocidal pyrazole derivatives |
CN102827073A (zh) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
MX355824B (es) | 2011-09-15 | 2018-05-02 | Bayer Ip Gmbh | Piperidinpirazoles como fungicidas. |
BR112014009086A2 (pt) | 2011-10-18 | 2017-05-09 | Syngenta Participations Ag | derivados pirazol microbicidas |
IN2014DN02890A (ru) | 2011-10-18 | 2015-06-26 | Syngenta Participations Ag | |
US8642774B2 (en) | 2011-12-08 | 2014-02-04 | Boehringer Ingelheim International Gmbh | Compounds |
EP2820015A1 (en) | 2012-03-02 | 2015-01-07 | Syngenta Participations AG | Microbiocidal pyrazole derivatives |
US20160007606A1 (en) | 2012-03-02 | 2016-01-14 | Syngenta Participations Ag | Microbiocidal pyrazole derivatives |
US10035790B2 (en) | 2012-10-19 | 2018-07-31 | Exelixis, Inc. | RORγ modulators |
WO2014075874A1 (en) | 2012-11-13 | 2014-05-22 | Syngenta Participations Ag | Microbiocidal pyrazole derivatives |
WO2014075873A1 (en) | 2012-11-13 | 2014-05-22 | Syngenta Participations Ag | Microbiocidal pyrazole derivatives |
-
2013
- 2013-02-01 JP JP2014555374A patent/JP6073931B2/ja active Active
- 2013-02-01 CN CN201380007926.7A patent/CN104093715B/zh active Active
- 2013-02-01 CA CA2861020A patent/CA2861020C/en active Active
- 2013-02-01 NZ NZ629795A patent/NZ629795A/en not_active IP Right Cessation
- 2013-02-01 EP EP13712913.6A patent/EP2809668B1/en active Active
- 2013-02-01 MY MYPI2014702122A patent/MY170524A/en unknown
- 2013-02-01 PL PL13712913T patent/PL2809668T3/pl unknown
- 2013-02-01 ES ES13712913.6T patent/ES2632237T3/es active Active
- 2013-02-01 EA EA201400854A patent/EA027595B1/ru not_active IP Right Cessation
- 2013-02-01 AU AU2013216354A patent/AU2013216354B2/en not_active Ceased
- 2013-02-01 US US14/376,307 patent/US9266876B2/en active Active
- 2013-02-01 BR BR112014018714A patent/BR112014018714A8/pt not_active IP Right Cessation
- 2013-02-01 UA UAA201409420A patent/UA113638C2/uk unknown
- 2013-02-01 MX MX2014009355A patent/MX352181B/es active IP Right Grant
- 2013-02-01 SG SG11201404144PA patent/SG11201404144PA/en unknown
- 2013-02-01 WO PCT/IB2013/050870 patent/WO2013114332A1/en active Application Filing
- 2013-02-01 KR KR1020147024508A patent/KR101800607B1/ko active IP Right Grant
-
2014
- 2014-07-03 PH PH12014501540A patent/PH12014501540A1/en unknown
- 2014-07-30 IL IL233872A patent/IL233872A/en not_active IP Right Cessation
- 2014-07-31 CL CL2014002048A patent/CL2014002048A1/es unknown
-
2015
- 2015-05-08 HK HK15104367.0A patent/HK1203939A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PH12014501540B1 (en) | 2014-09-22 |
BR112014018714A2 (ru) | 2017-06-20 |
US20140371204A1 (en) | 2014-12-18 |
MY170524A (en) | 2019-08-09 |
JP6073931B2 (ja) | 2017-02-01 |
KR101800607B1 (ko) | 2017-11-23 |
EP2809668B1 (en) | 2017-04-12 |
EA201400854A1 (ru) | 2015-04-30 |
EA027595B1 (ru) | 2017-08-31 |
CL2014002048A1 (es) | 2014-11-14 |
CA2861020C (en) | 2018-07-17 |
WO2013114332A1 (en) | 2013-08-08 |
UA113638C2 (xx) | 2017-02-27 |
IL233872A (en) | 2017-05-29 |
EP2809668A1 (en) | 2014-12-10 |
CN104093715A (zh) | 2014-10-08 |
MX2014009355A (es) | 2014-09-01 |
CA2861020A1 (en) | 2013-08-08 |
HK1203939A1 (en) | 2015-11-06 |
MX352181B (es) | 2017-11-13 |
BR112014018714A8 (pt) | 2017-12-26 |
PL2809668T3 (pl) | 2018-02-28 |
KR20140120364A (ko) | 2014-10-13 |
CN104093715B (zh) | 2017-04-26 |
AU2013216354B2 (en) | 2017-08-31 |
AU2013216354A1 (en) | 2014-09-25 |
NZ629795A (en) | 2016-06-24 |
PH12014501540A1 (en) | 2014-09-22 |
US9266876B2 (en) | 2016-02-23 |
JP2015506957A (ja) | 2015-03-05 |
ES2632237T3 (es) | 2017-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1207069A1 (en) | Heterocyclic compounds and uses thereof | |
HK1199725A1 (en) | Heterocyclic compounds and uses thereof | |
HK1198475A1 (en) | Heterocyclic compounds and uses thereof | |
HK1198443A1 (en) | Heterocyclic compounds and uses thereof | |
HK1193561A1 (zh) | 雜環化合物和其用途 | |
HK1203939A1 (en) | 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives 4-(-2-)- | |
HK1203927A1 (en) | Heterocyclic compounds and uses as anticancer agents | |
HK1210769A1 (en) | Heterocyclic compound | |
EP2889291A4 (en) | HETEROCYCLIC CONNECTION | |
EP2821401A4 (en) | HETEROCYCLIC COMPOUND AND USE THEREOF | |
HK1201521A1 (en) | Heterocyclic compounds and methods for their use | |
EP2873669A4 (en) | HETEROCYCLIC COMPOUND | |
EP2832734A4 (en) | HETEROCYCLIC CONNECTION | |
HK1201533A1 (en) | Heterocyclic compounds and methods for their use | |
HK1201531A1 (en) | Heterocyclic compounds and methods for their use | |
EP2818473A4 (en) | HETEROCYCLIC COMPOUND | |
EP2886546A4 (en) | Heterocyclic compound and use thereof | |
EP2927229A4 (en) | HETEROCYCLIC COMPOUND | |
EP2857400A4 (en) | HETEROCYCLIC COMPOUND | |
AP3611A (en) | Heterocyclic compounds and their uses | |
EP2813508A4 (en) | HETEROCYCLIC COMPOUND AND APPLICATION THEREOF | |
EP2782571A4 (en) | HETEROCYCLIC COMPOUNDS AND USES THEREOF |